A detailed history of Jane Street Group, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Jane Street Group, LLC holds 36,475 shares of ZLAB stock, worth $956,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,475
Previous 174,039 79.04%
Holding current value
$956,739
Previous $3.02 Million 70.82%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.25 - $24.14 $2.24 Million - $3.32 Million
-137,564 Reduced 79.04%
36,475 $880,000
Q2 2024

Aug 14, 2024

BUY
$13.72 - $21.55 $598,466 - $940,011
43,620 Added 33.45%
174,039 $3.02 Million
Q1 2024

May 15, 2024

SELL
$15.95 - $26.8 $373,628 - $627,790
-23,425 Reduced 15.23%
130,419 $2.09 Million
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $2.86 Million - $3.81 Million
124,462 Added 423.6%
153,844 $4.2 Million
Q3 2023

Nov 14, 2023

SELL
$22.72 - $31.49 $37,647 - $52,178
-1,657 Reduced 5.34%
29,382 $714,000
Q2 2023

Aug 14, 2023

BUY
$25.3 - $39.67 $785,286 - $1.23 Million
31,039 New
31,039 $860,000
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $210,390 - $365,538
9,443 Added 63.53%
24,306 $746,000
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $508,314 - $768,268
14,863 New
14,863 $508,000
Q2 2022

Aug 16, 2022

SELL
$23.14 - $49.68 $881,819 - $1.89 Million
-38,108 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$27.77 - $64.4 $569,784 - $1.32 Million
20,518 Added 116.65%
38,108 $1.68 Million
Q4 2021

Feb 15, 2022

SELL
$54.9 - $105.21 $1.54 Million - $2.95 Million
-28,065 Reduced 61.47%
17,590 $1.11 Million
Q3 2021

Nov 16, 2021

BUY
$105.0 - $178.37 $4.11 Million - $6.97 Million
39,104 Added 596.92%
45,655 $4.81 Million
Q2 2021

Aug 16, 2021

SELL
$125.11 - $180.0 $528,214 - $759,960
-4,222 Reduced 39.19%
6,551 $1.16 Million
Q1 2021

May 18, 2021

BUY
$126.27 - $191.71 $710,521 - $1.08 Million
5,627 Added 109.35%
10,773 $1.44 Million
Q4 2020

Feb 17, 2021

SELL
$81.94 - $135.34 $8,767 - $14,481
-107 Reduced 2.04%
5,146 $696,000
Q3 2020

Nov 17, 2020

SELL
$73.3 - $89.48 $128,055 - $156,321
-1,747 Reduced 24.96%
5,253 $437,000
Q2 2020

Aug 17, 2020

BUY
$48.82 - $82.53 $63,661 - $107,619
1,304 Added 22.89%
7,000 $575,000
Q1 2020

May 15, 2020

BUY
$39.1 - $62.9 $222,713 - $358,278
5,696 New
5,696 $293,000
Q4 2018

Feb 15, 2019

SELL
$14.95 - $24.72 $542,415 - $896,891
-36,282 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$17.8 - $25.35 $645,819 - $919,748
36,282 New
36,282 $707,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.57B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.